Cargando…
CCL19: a novel prognostic chemokine modulates the tumor immune microenvironment and outcomes of cancers
Background: CCL19 is a chemokine involved in cancer research due to its important role in the tumor microenvironment (TME) and clinical relevance in cancers. This study aimed to analyze transcription expression, genomic alteration, association with tumor immune microenvironment of CCL19 expression a...
Autores principales: | Gu, Qiang, Zhou, Shifang, Chen, Cong, Wang, Zhi, Xu, Wenhao, Zhang, Jiarong, Wei, Shiyin, Yang, Jianfeng, Chen, Hongjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683612/ https://www.ncbi.nlm.nih.gov/pubmed/37944262 http://dx.doi.org/10.18632/aging.205184 |
Ejemplares similares
-
Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma
por: Xu, Wenhao, et al.
Publicado: (2022) -
Resident stroma-secreted chemokine CCL2 governs myeloid-derived suppressor cells in the tumor microenvironment
por: Oo, May Wathone, et al.
Publicado: (2022) -
Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy
por: Bule, Pedro, et al.
Publicado: (2021) -
The Mucosae-Associated Epithelial Chemokine (MEC/CCL28) Modulates Immunity in HIV Infection
por: Castelletti, Eleonora, et al.
Publicado: (2007) -
CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment
por: Lecoq, Inés, et al.
Publicado: (2022)